MICHELLE SWINYER: Open Payments
NPI 1841923638 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 31 payments from 9 companies in 2025. Trend: 2023 $649 · 2024 $866 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $287 |
| Novo Nordisk Inc | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Impulse Dynamics (USA) Inc. | 1 | $26 |
| PFIZER INC. | 1 | $14 |
Products named: REPATHA, Wegovy, ONPATTRO, NEXLETOL, CAMZYOS, Optimizer, FARXIGA, LEQVIO.
Industry payments across NC — which companies pay providers there.
